Belarus development bank backs hospital projects

Region:

Europe

Development Bank of the Republic of Belarus is providing loans to build a healthcare complex in Brest and to reconstruct City Clinical Hospital No.3 in Grodno. The Development Bank will provide a loan of BYR25 million ($10.46 million) to Brest in 2020-2022 and BYR53.8 million to Grodno in 2020-2025.

The Brest loan will be repaid from national budget funds set aside to finance state investment programs in 2020-2029. The loan to reconstruct the hospital in Grodno will be repaid from the Grodno Oblast budget.

View source

Video

11 June 2026

COFIDES steps ahead: Catalysing private capital, originating...

Ángela Pérez, CEO and chair at COFIDES, spoke to Uxolo at the lill Global Symposium 2026 in Oxford. Here she talks risk-sharing and catalysing private capital in the...

Life sciences: DFIs test a new frontier in health PPP

Perspective

11 June 2026

Life sciences: DFIs test a new frontier in health PPP

Biovac’s EU-backed quasi-equity package and Brazil’s planned $1.2 billion vaccine PPP suggest that life-sciences are increasingly viewed as social infrastructure. But even...

Must See

Green Sky SAF: An Egypt first with lending precedents

Perspective

04 June 2026

Green Sky SAF: An Egypt first with lending precedents

A landmark sustainable aviation fuel project in Egypt shows that commercial banks and local equity can get behind emerging transportation fuels. But shared experience on an earlier SAF financing helped assure a painless close.

Video

11 June 2026

COFIDES steps ahead: Catalysing private capital, originating deals, and learning to measure impact

Ángela Pérez, CEO and chair at COFIDES, spoke to Uxolo at the lill Global Symposium 2026 in Oxford. Here she talks risk-sharing and catalysing private capital in the development finance industry.

Perspective

11 June 2026

Life sciences: DFIs test a new frontier in health PPP

Biovac’s EU-backed quasi-equity package and Brazil’s planned $1.2 billion vaccine PPP suggest that life-sciences are increasingly viewed as social infrastructure. But even vaccine sovereignty is hard to bank without public risk-sharing, demand visibility and unusually credible developers.